ZBTB7A, though its proper function in the breast cancer pathway is unknown, acts as a tumor suppressor making it a novel target for combating breast cancer, while PATZ1 possesses the potential for being a suitable candidate for the suppression of cancer. Here, ZBTB7A is linked to cancer.